Sign Up to like & get
recommendations!
1
Published in 2019 at "International Journal of Clinical Pharmacology and Therapeutics"
DOI: 10.5414/cp203343
Abstract: Objective: Ertugliflozin is approved in the US and European Union as a stand-alone product for adults with type 2 diabetes mellitus as once daily (QD) dosing. The approved fixed-dose combination (FDC) of ertugliflozin and immediate-release…
read more here.
Keywords:
twice daily;
daily dosing;
healthy subjects;
bid ... See more keywords